Dr. Ervinna Pang, Phd, Cva Email & Phone Number

Singapore

Singapore

BioCheetah is a Medtech (in vitro diagnostics/IVD) company that develops a proprietary set of novel biomarkers and detection antibodies for diagnostic applications. Its most advanced non-invasive, protein-based ELISA test kit, for diagnosis and monitoring of bladder cancer is available as a lab-developed test (LDT) and will be launched soon as IVD for.

Singapore

co11ab is Singapore's first BioMedtech incubator embedded within a health city (HealthCity Novena). It is a tripartite alliance between Nanyang Technological University, Singapore (NTU), Agency for Science, Technology and Research, Singapore (A*STAR) and National Healthcare Group, Singapore (NHG). Its mission is to nurture and support development of.

Singapore And China

Singapore And China

BioSyngen is a clinical-stage cell therapy Biotech company, developing multiple T-cell immunotherapies to address unmet needs in oncology.BioSyngen operates GMP-compliance facilities for cell therapy in Singapore and China.

Singapore

ImmuNOA is a genetic engineering (antisense therapy) Biotech company. We rationally design and test our proprietary library of antisense oligonucleotides to improve immunotherapy efficacy in the treatment of multiple pathologies.Multiple proprietary antisense oligonucleotides against different checkpoint inhibitors have been deployed to transiently modify.

Singapore

Singapore And China

Singapore And China

Lion TCR is a clinical-stage TCR-T cell therapy Biotech company that discovers, develops, and commercializes first-in-class and best-in-class TCR-T cell therapy against viral infections and related cancers.Lion TCR operates GMP-compliance facilities for cell therapy.

Singapore And China

SCG Cell Therapy is a clinical-stage Biotech company focusing on the development of novel immunotherapies for patients with pathogenic infections and associated cancers. SCG Cell Therapy operates GMP-compliance facilities for cell therapy.

China

Part of global Boehringer Ingelheim (BI)’s Research Beyond Borders (RBB). As “radar” for the next big wave of innovation, RBB explores emerging science and technologies both within and beyond BI’s core therapeutic areas. New frontiers in science involved were Gene therapy (Adeno-Associated Virus/AAV) and Regenerative medicine. Therapeutic areas involved.

Singapore

Innovation and Enterprise unit of A*STAR (formerly known as Exploit Technologies Pte Ltd or Accelerate Technologies Pte Ltd).Division PharmBiotech: Business Development & Licensing.

Global Therapeutic Research Groups (Oncology)- Germany

Cancer Immunotherapy

Global External Innovation & Alliances- APAC

External partnerships (from target discovery to Ph. I clinical trial)

Germany

Research disciplines: Molecular Biology, Oncology, Infection Biology, Immunology.Topics: *The Helicobacter pylori virulence effector CagA abrogates Human β-Defensin 3 expression via inactivation of EGFR signaling (published in Cell Host & Microbe, 2012).*Helicobacter pylori depletes cholesterol in gastric glands to prevent Interferon Gamma signaling and.

Singapore

Singapore OncoGenome Project (Prof Axel Ullrich's lab): set up and screened for potential tyrosine kinase inhibitors of fibroblast growth factor receptor 4 (FGFR4).

Singapore

*Development and production of monoclonal antibodies specific for Campylobacter jejuni and Campylobacter coli - results were translated into commercial antibodies for C. jejuni and C. coli detection.*Creation and screening of potential live attenuated vaccine of Salmonella Enteritidis.

Doctor Of Philosophy (Phd), Molecular Biology

- Max Planck Society (Germany) fellowship recipient. - German Research Foundation (DFG, GRK1673, Germany) fellowship recipient.

Chartered Valuer And Appraiser (Cva)

Professional certification in business and assets valuation. Institute of Valuers and Appraisers Singapore (IVAS) is a member of the.

Advanced Certificate In Sustainability And Sustainable Businesses

In partnership with Global Compact Network Singapore (Singapore chapter of the United Nations Global Compact). Sustainable Finance, Impact.

Graduate Certificate In Directorship

Executive Education by Singapore Management University and Singapore Institute of Directors.

Entrepreneurship Specialization Program

Developing opportunity, Launching start-up, Growth strategies, Financing and profitability.

Mba Foundation Series: Operations Management, Marketing, Financial Accounting, Corporate Finance

Master Of Philosophy (Mphil), Medicine

Sydney Head and Neck Cancer Institute, Sydney Cancer Centre (Australia) postgraduate research scholarship recipient.

Bachelor Of Science (Bsc), Biotechnology

Monash University undergraduate entrance scholarship recipient.